The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

SOHO 2019 | How should we treat bone disease in 2019?

Sep 17, 2019

During SOHO 2019, Houston, US, the Multiple Myeloma Hub were pleased to interview Dr Matthew T. Drake from Mayo Clinic, Rochester, US, about his preferred therapy for the treatment of bone disease.

He explains mechanisms of action of drugs approved for management of bone loss, denosumab and bisphosphonates.

How should we treat bone disease in 2019?